KendleWits
As the first international CRO to enter China, KendleWits has conducted more than 200 studies in China since 1997. Currently, they provide a strategic base of operations in Beijing, China, with highly qualified, dedicated CRAs, all extensively trained in compliance with ICH GCP standards. All the clinical monitoring staff holds a medical and/or pharmacy degree. With the advantage of broad patient population, accelerated patient recruitment, high trial quality and reasonable costs, KendleWits provides a strong presence as a leading CRO in China; offering full service Phase I - IV clinical trials.| Type: | NORMAL |
| Address: | Room 1502-1505 Tower B, Global Trade Center, N.36 East, Third Ring North Road, Dongcheng District, Beijing 100013 |
| Website: | www.kendlewits.com.cn |
| Phone: | +86 10 5825 6060 |
| Fax: | +86 10 5825 6055 |